Regulation of the Human Papillomavirus Life Cycle by the Long Noncoding RNA DINO

长非编码 RNA DINO 对人乳头瘤病毒生命周期的调节

基本信息

  • 批准号:
    10743142
  • 负责人:
  • 金额:
    $ 41.84万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-06-01 至 2028-05-31
  • 项目状态:
    未结题

项目摘要

Despite the currently available effective prophylactic vaccines, human papilloma virus infections remain the most common cause of venereal disease. Human papilloma virus-associated diseases are particularly prevalent in medically underserved segments of the population. Despite decades of research, there are no strategies that can limit the spread of human papilloma viruses. The productive viral life cycle of these viruses has been studied extensively, but research has almost exclusively focused on the contributions of viral and cellular proteins and protein-coding mRNAs. However, most of the cellular transcriptome does not encode proteins. Some non-coding RNAs likely represent functionally irrelevant transcriptional noise but several classes of non-coding RNAs serve important regulatory functions. Long non-coding RNAs have only recently emerged as critical modulators of many cellular regulatory circuits. Human papilloma viruses replicate their genomes to high copy numbers and generate progeny virus in terminally differentiated epithelial cells. We showed that expression of the long non-coding RNA DINO increases during epithelial differentiation and that ectopic expression of the long noncoding RNA DINO in a patient-derived, human papillomavirus episome- containing cell line causes an increase in viral genomes. This proposal addresses the hypothesis that DINO plays a previously unanticipated role in regulating the differentiation-dependent life cycle of human papillomaviruses. We will deploy a combination of biochemical, cell and molecular biology approaches to define the biological activities of DINO in human papillomavirus genome replication in dividing and differentiated viral episome-containing, patient-derived cell lines. The results from our studies will yield novel molecular insights into the differentiation-dependent life cycle of human papillomaviruses.
尽管目前已有有效的预防性疫苗,但人乳头瘤病毒感染仍然是性病最常见的原因。人乳头瘤病毒相关疾病在医疗服务不足的人群中特别普遍。尽管进行了数十年的研究,但没有任何策略可以限制人乳头状瘤病毒的传播。这些病毒的生产性病毒生命周期已被广泛研究,但研究几乎完全集中在病毒和细胞蛋白以及蛋白编码mRNA的贡献上。然而,大多数细胞转录组不编码蛋白质。一些非编码RNA可能代表功能上不相关的转录噪音,但几类非编码RNA具有重要的调控功能。长的非编码RNA只是最近才出现作为许多细胞调节回路的关键调节剂。人乳头瘤病毒复制其基因组到高拷贝数,并在终末分化的上皮细胞中产生子代病毒。我们发现,长的非编码RNA DINO的表达在上皮分化过程中增加,并且长的非编码RNA DINO在患者来源的含有人乳头瘤病毒附加体的细胞系中的异位表达导致病毒基因组的增加。该提案解决了DINO在调节人乳头瘤病毒的分化依赖性生命周期中发挥先前未预料到的作用的假设。我们将部署生物化学,细胞和分子生物学方法的组合,以确定DINO在分裂和分化的含病毒游离体的患者源性细胞系中人乳头瘤病毒基因组复制中的生物活性。我们的研究结果将为人类乳头瘤病毒的分化依赖性生命周期提供新的分子见解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Karl Munger其他文献

Karl Munger的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Karl Munger', 18)}}的其他基金

Mechanistic studies on the unique set of accessory proteins encoded by the gamma 6 human papillomaviruses
γ 6 人乳头瘤病毒编码的一组独特辅助蛋白的机制研究
  • 批准号:
    10495249
  • 财政年份:
    2021
  • 资助金额:
    $ 41.84万
  • 项目类别:
Mechanistic studies on the unique set of accessory proteins encoded by the gamma 6 human papillomaviruses
γ 6 人乳头瘤病毒编码的一组独特辅助蛋白的机制研究
  • 批准号:
    10349083
  • 财政年份:
    2021
  • 资助金额:
    $ 41.84万
  • 项目类别:
NHLBI Short-Term Training Program Increase Diversity in Health-Related Research
NHLBI 短期培训计划增加健康相关研究的多样性
  • 批准号:
    7619109
  • 财政年份:
    2007
  • 资助金额:
    $ 41.84万
  • 项目类别:
NHLBI Short-Term Training Program to Increase Diversity in Health-Related Researc
NHLBI 短期培训计划,以增加健康相关研究的多样性
  • 批准号:
    7802241
  • 财政年份:
    2007
  • 资助金额:
    $ 41.84万
  • 项目类别:
NHLBI Short-Term Training Program to Increase Diversity in Health-Related Researc
NHLBI 短期培训计划,以增加健康相关研究的多样性
  • 批准号:
    8066585
  • 财政年份:
    2007
  • 资助金额:
    $ 41.84万
  • 项目类别:
NHLBI Short-Term Training Program Increase Diversity in Health-Related Research
NHLBI 短期培训计划增加健康相关研究的多样性
  • 批准号:
    7286178
  • 财政年份:
    2007
  • 资助金额:
    $ 41.84万
  • 项目类别:
NHLBI Short-Term Training Program Increase Diversity in Health-Related Research
NHLBI 短期培训计划增加健康相关研究的多样性
  • 批准号:
    7415223
  • 财政年份:
    2007
  • 资助金额:
    $ 41.84万
  • 项目类别:
HPV AND CELL CYCLE DYSREGULATION IN ORAL CANCER
口腔癌中的 HPV 和细胞周期失调
  • 批准号:
    6590274
  • 财政年份:
    2002
  • 资助金额:
    $ 41.84万
  • 项目类别:
MODULATION OF HOST CELL APOPTOTIC RESPONSES BY HPVE7
HPVE7 对宿主细胞凋亡反应的调节
  • 批准号:
    6497542
  • 财政年份:
    2000
  • 资助金额:
    $ 41.84万
  • 项目类别:
Modulation of Host Cell Apoptotic Responses by HPVE7
HPVE7 对宿主细胞凋亡反应的调节
  • 批准号:
    7013214
  • 财政年份:
    2000
  • 资助金额:
    $ 41.84万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 41.84万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.84万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 41.84万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.84万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 41.84万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.84万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 41.84万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 41.84万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 41.84万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.84万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了